LFCR
Lifecore Biomedical, Inc.
There isn't enough reported data to score LFCR yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
LFCR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Stable | |
| Weak |
LFCR's cash flow is currently stable, but its profitability and balance sheet are weak. There isn't enough data to rate its revenue.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LFCR PE Valuation
LFCR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
LFCR Forward outlook
There aren't enough analyst estimates for LFCR to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LFCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.16 | +$0.11 |
| Q2 2025 | -$1.27 | -497% |
| Q1 2025 | -$1.39 | -$0.53 |
| Q4 2024 | -$0.50 | +$2.11 |
| Q3 2024 | $0.14 | +$3.56 |
| Q2 2024 | $0.32 | +$3.77 |
| Q1 2024 | -$0.86 | +$3.11 |
| Q4 2023 | -$2.61 | +$0.46 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 490% for LFCR versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
LFCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.3M | -19% |
| Q2 2026 | $34.2M | -6.2% |
| Q1 2026 | $23.2M | -34% |
| Q4 2025 | $44.4M | +36% |
| Q3 2025 | $31.1M | +26% |
| Q2 2025 | $36.4M | -3.8% |
| Q1 2025 | $35.2M | -1.5% |
| Q4 2024 | $32.6M | +8% |
LFCR's revenue has slid since its 2020 peak: $25M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.5% | +6.3 points |
| Q2 2026 | 7.5% | -7.1 points |
| Q1 2026 | -20% | +5.5 points |
| Q3 2025 | -9.9% | +37 points |
| Q2 2025 | 15% | +8.9 points |
| Q1 2025 | -26% | -23 points |
| Q4 2024 | -6% | -1.1 points |
| Q3 2024 | -47% | -12 points |
LFCR's operating margin was −3.5% last quarter, down 18 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over LFCR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over LFCR on profitability, with a higher operating margin.
LFCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6M | +24036% |
| Q2 2026 | -$2.7M | -183% |
| Q1 2026 | $3.6M | +$7.8M |
| Q4 2025 | -$986.3K | +$7.6M |
| Q3 2025 | $25K | +$4.1M |
| Q2 2025 | $3.3M | -62% |
| Q1 2025 | -$4.3M | +$3.5M |
| Q4 2024 | -$8.6M | -$5.6M |
LFCR's free cash flow has turned positive after six years mostly in the red: $6M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
LFCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +271K shares |
| 1 year | +1.2% | +443K shares |
| 3 years | +24% | +7.4M shares |
| 5 years | +29% | +8.4M shares |
| Available history | +30% | +8.7M shares |
LFCR has 38M diluted shares, up 1.2% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over LFCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
LFCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | 5,820.6x | High |
| Q3 2021 | 8.2x | High |
| Q2 2021 | 25.7x | High |
| Q4 2019 | 8.5x | High |
LFCR's net debt is more than 20 years of its operating earnings (EBITDA).
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
LFCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.6 | Neutral |
| Stochastic | 90.1 | Overbought |
LFCR's weekly RSI is 61 (neutral) and its Stochastic is 90 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
LFCR PE vs Healthcare Sector
| Metric | LFCR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
LFCR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
LFCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.14 | 4.2% above |
| 20 week MA | $5.21 | 23% above |
| 50 week MA | $5.85 | 9.4% above |
| 100 week MA | $6.38 | 0.3% above |
| 200 week MA | $6.45 | 0.8% below |
LFCR has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 0.8% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
LFCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $10.1 | -12% |
| 2021 | $10.1 | $11.0 | +8.7% |
| 2022 | $11.0 | $6.93 | -37% |
| 2023 | $6.93 | $6.19 | -11% |
| 2024 | $6.19 | $7.28 | +18% |
| 2025 | $7.28 | $8.30 | +14% |
| 2026 YTD | $8.30 | $6.40 | -23% |
LFCR has finished lower in three of the last six years. It's down 23% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over LFCR on returns for 2026, with the stronger performance.